Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Contract Pharma: ‘A Modern CDMO’ article

Our Head of Drug Substance, Paul Quigley, recently shared his thoughts on the importance of flexibility, collaboration and innovation for the modern CDMO. In his article for Contract Pharma, Paul explains the greater need for more effective process solutions during drug development and how successful contract service organisations are meeting this challenge. He also defines the Arcinova model for accelerated delivery, through integrated services and technological innovation.
Read the article in ContractPharma




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH